Suven Life Sciences Ltd. is a biopharmaceutical company engaged primarily in the research, development, and manufacture of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company focuses on the creation and commercialization of novel therapeutic entities (NCEs) for the treatment of neurological disorders, including cognitive impairment and depression. Suven Life Sciences operates in the pharmaceutical industry, directly impacting the healthcare and biotechnology sectors. With international operations and collaborations with global pharmaceutical entities, the company plays a significant role in advancing mental health treatment options. Headquartered in India, Suven Life Sciences contributes to the global effort to address unmet medical needs within the rapidly evolving pharmaceutical landscape.